Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    FDA Seeks Immunoassay System for Tox Research

    By Global Biodefense StaffFebruary 4, 2016
    Share
    Facebook LinkedIn Reddit Email

    The FDA’s National Center for Toxicological Research (NCTR) is conducting a market survey for immunoassay systems to detect cardiac toxicity biomarkers.

    Drug-induced cardiac toxicity is one of the common adverse effects which cause the FDA concern. The level of cardiac troponin I, one of the most commonly used cardiac injury biomarkers, needs to be measured to help access the severity of drug-induced cardiac injury.

    One of the challenges NCTR is facing is the low level of troponin I in mouse plasma compared to human plasma. NCTR requires an Immunoassay System that can quantify the cardiac troponin I efficiently with high sensitivity in mouse plasma. The data gained from this instrument will directly help to interpret the drug treatment effect.

    System capabilities must include:

    • Beaded-based, fluorescence-coupled, single-molecule counting for ultra-sensitivity and low background.
    • Low limit of detection at 0.1 picogram/milliliter for Troponin I assay.
    • Linear dynamic range of up to 4 orders of magnitude for detection.
    • High precision counting with low end average cardiovascular (CV) less than 12 percent for Troponin I assay.
    • Small volume (down to 50 microliters) needed for each assay.

    Further details are available via Solicitation Number: FDA1161996. The response deadline is February 11, 2016.

    Biomarkers
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleSuperbugs and Superdrugs: An Interview with BARDA
    Next Article The Global Mission of the DoD Chemical-Biological Program

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.